Vanda pharmaceuticals inc. (VNDA)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities
Net Income (Loss) Attributable to Parent

116,651

115,553

121,697

28,445

21,530

25,208

13,010

1,289

-4,856

-15,567

-14,333

-10,213

-13,297

-18,010

-32,204

-41,234

-42,002

-39,865

44,652

52,687

36,498

20,186

-57,280

-61,261

-43,069

-21,055

-19,677

-19,597

-24,221

-27,664

-26,818

-24,566

-17,900

-9,802

0

0

0

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation of property and equipment

1,419

1,400

1,365

1,366

1,383

1,400

1,362

1,353

1,299

1,200

1,141

1,018

931

900

816

754

661

582

554

529

545

530

507

484

450

432

426

421

409

633

713

755

723

469

0

0

0

Stock-based compensation

14,120

13,458

12,712

12,177

11,797

11,666

11,526

11,425

11,360

10,465

9,786

9,115

8,533

8,543

8,327

8,288

8,282

7,961

7,705

7,055

6,430

5,878

5,654

5,808

5,499

5,404

4,920

3,931

3,990

4,094

4,489

5,167

5,299

5,501

0

0

0

Amortization of discounts and premiums on marketable securities

2,480

3,099

3,462

3,397

2,919

2,221

1,538

951

581

426

288

128

19

-62

-141

-294

-508

-677

-654

-504

-318

-174

-166

-130

-88

-155

-265

-399

-563

-560

-542

-608

-702

-900

0

0

0

Intangible asset amortization

1,525

1,505

1,480

1,577

1,507

1,527

1,579

1,614

1,696

1,750

3,423

5,934

8,444

10,933

11,771

11,771

11,771

12,972

10,565

8,158

5,833

2,254

2,095

1,936

1,691

1,495

1,495

1,495

1,495

1,495

1,495

1,495

1,495

1,495

0

0

0

Deferred income taxes

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-cash adjustments, net

-1,782

-1,785

-1,531

-794

-597

-167

-341

-490

-341

-587

-458

-526

-663

-542

-307

-395

-256

-483

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Landlord contributions for tenant improvements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,826

0

0

0

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

2,997

-2,342

1,607

-938

3,060

11,207

7,250

4,013

5,704

-2,525

2,261

7,124

1,434

4,298

490

-1,557

-3,441

12,677

12,093

13,442

18,429

1,623

1,740

735

229

863

421

-59

-73

-450

319

948

640

1,107

0

0

0

Prepaid expenses and other assets

6,535

2,764

3,278

-166

2,748

4,258

1,307

-3,830

-2,835

-3,652

-263

5,500

5,121

6,159

1,065

3,266

4,623

2,558

6,128

2,727

-692

318

1,373

1,515

-156

-1,264

-1,072

-937

640

884

1,527

1,396

1,029

1,240

0

0

0

Accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-721

-522

333

-709

-243

352

-54

348

0

0

0

Inventory

602

722

1,041

50

37

-70

-51

1,124

914

1,060

759

-456

-75

-200

3

84

-474

-387

489

909

2,063

2,210

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and other liabilities

-1,794

3,508

5,755

6,109

5,620

-618

-1,781

1,739

1,780

5,953

3,397

840

-4,938

575

3,425

3,067

5,534

9,432

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product revenue allowances

1,239

761

5,358

6,002

4,244

8,223

2,162

-4,023

-2,230

-11,096

-7,494

-2,518

-2,433

-1,426

1,699

5,090

17,693

35,055

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

363

622

834

265

371

292

71

424

0

0

0

Accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-2,221

-2,138

-1,497

1,806

3,122

3,174

3,009

1,836

0

0

0

Accrued income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,266

0

0

0

Deferred licensing revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-30,572

-29,733

-28,721

-27,635

-26,789

-26,789

-26,789

-26,789

-26,789

-26,789

-26,789

-26,789

-26,789

0

0

0

Net cash provided by operating activities

35,397

45,947

51,419

54,115

37,991

29,986

18,189

11,663

5,012

-1,983

-6,632

-7,559

-8,561

-8,103

-7,276

-13,368

1,995

12,449

-581

-3,329

-52,095

-81,554

-80,321

-82,993

-54,371

-39,592

-41,288

-41,181

-45,352

-44,917

-43,425

-40,431

-33,836

-28,410

0

0

0

Cash flows from investing activities
Acquisition of intangible asset

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

999

1,019

973

815

626

368

537

772

1,321

1,664

0

0

0

-

-

-

-

2,527

2,151

1,330

1,417

769

528

482

288

176

86

96

195

2,017

0

0

0

-

-

-

-

Purchases of marketable securities

335,114

394,517

371,788

343,152

352,765

282,395

240,679

197,500

125,101

148,135

143,943

142,583

171,561

165,405

196,360

215,756

180,532

193,111

180,569

154,147

150,914

93,343

0

0

0

-

-

-

-

60,866

69,543

120,604

142,007

160,213

0

0

0

Proceeds from sale of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,948

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Maturities of marketable securities

324,555

327,227

294,878

271,053

215,968

198,103

179,721

151,086

149,671

139,568

136,655

132,487

153,481

156,787

184,039

201,063

181,019

168,041

122,201

100,202

104,487

80,882

56,091

31,234

4,499

31,499

40,500

60,309

76,740

106,140

148,060

196,951

225,445

226,170

0

0

0

Change in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-245

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-11,558

-68,309

-77,883

-72,914

-162,423

-109,660

-86,495

-72,186

23,249

-10,231

-9,458

-12,494

-19,965

-10,025

-13,745

-16,392

-258

-26,598

-59,520

-53,526

-45,994

-12,037

-49,225

-54,947

-64,363

-34,275

29,515

49,813

47,370

45,754

87,594

84,408

89,385

73,749

0

0

0

Cash flows from financing activities
Proceeds from Issuance of Common Stock

-

-

-

-

-

100,870

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from Stock Options Exercised

6,600

6,300

4,900

4,500

3,834

6,300

5,630

6,298

5,757

5,300

5,920

11,114

9,936

7,751

7,001

4,618

4,195

4,374

4,548

1,167

607

2,851

3,165

3,232

3,995

1,550

0

0

0

-

-

-

-

-

-

-

-

Tax obligations paid in connection with settlement of restricted stock units

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

283

282

282

282

436

436

436

437

196

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by financing activities

6,564

6,264

4,940

4,494

3,571

107,126

106,415

107,071

106,776

5,251

5,920

11,114

9,936

7,751

7,000

4,617

4,194

4,091

91,579

88,198

87,638

89,728

2,682

51,301

52,063

49,859

0

0

0

-

-

-

-

-

-

-

-

Effect of exchange rate changes on cash, cash equivalents and restricted cash

2

-1

-48

-43

-54

-38

-6

22

59

42

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net change in cash, cash equivalents and restricted cash

30,405

-16,099

-21,572

-14,348

-120,915

27,414

38,103

46,570

135,096

-6,921

-10,131

-8,914

-18,584

-10,372

-14,021

-25,143

5,931

-10,058

31,478

31,343

-10,451

-3,863

-126,864

-86,639

-66,671

-24,008

37,657

9,245

1,837

849

44,189

44,002

55,574

45,364

0

0

0